Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.
about
Novel non-AR therapeutic targets in castrate resistant prostate cancerNucleic acid-based biomarkers in body fluids of patients with urologic malignancies.DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.
P2860
Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Molecular pathology of prostat ...... me-based personalized therapy.
@ast
Molecular pathology of prostat ...... me-based personalized therapy.
@en
type
label
Molecular pathology of prostat ...... me-based personalized therapy.
@ast
Molecular pathology of prostat ...... me-based personalized therapy.
@en
prefLabel
Molecular pathology of prostat ...... me-based personalized therapy.
@ast
Molecular pathology of prostat ...... me-based personalized therapy.
@en
P2093
P2860
P1476
Molecular pathology of prostat ...... me-based personalized therapy.
@en
P2093
Jason K Wang
Jiaoti Huang
P2860
P304
P356
10.1097/MOU.0B013E32835E9EF4
P577
2013-05-01T00:00:00Z